Study of Botulinum Toxin in Patients With Primary Hyperhidrosis

Icahn School of Medicine at Mount Sinai1 个研究点分布在 1 个国家开始时间: 1999年7月1日最近更新: 2005年6月24日

适应症

试验速览

阶段: 不适用
状态: 已完成
发起方: Icahn School of Medicine at Mount Sinai
试验地点: 1

研究概览研究设计入排标准研究者研究点记录与标识符相似试验

研究概览

简要总结

OBJECTIVES:

I. Determine the optimal dose of botulinum toxin necessary to decrease sweating in patients with primary hyperhidrosis.

详细描述

PROTOCOL OUTLINE:

Patients receive injections of botulinum toxin in the clinical trial for 6 months. Patients undergo an iodine starch test and a sympathetic skin response test to assess the efficacy of the drug. Patients also complete questionnaires to evaluate the amount of sweating.

研究设计

研究类型: Interventional
主要目的: Treatment

入排标准

年龄范围: 16 Years 至 —（Child, Adult, Older Adult）
性别: All
接受健康志愿者: 否

入选标准

•Diagnosis of hyperhidrosis
•Excessive sweating in the hands, feet, armpits, forehead, or body

排除标准

未提供

研究者

发起方

Icahn School of Medicine at Mount Sinai

申办方类型

Other

研究点 (1)

Loading locations...

相似试验

已完成

4 期

The Effect of Subcutaneous Injection of Botulinum Toxin A on Chronic Wound Pain in Lower ExtremitiesChronic PainLower Extremity Wound

NCT05426161Bispebjerg Hospital10

终止

2 期

Efficacy and Safety Study of Botulinum Toxin Type-A (Dysport®) in Continent Female Subjects Suffering From Idiopathic Overactive BladderOveractive Bladder

NCT00578097Ipsen81

Unknown

4 期

Efficacy Study of Botox for DepressionMajor Depression

NCT01556971Capital Clinical Research Associates, LLC60

终止

4 期

Botulinum Toxin Type A (Botox) in the Management of Levodopa-Induced Peak-Dose Dyskinesias in Parkinson's DiseaseParkinson Disease

NCT00477802University of Cincinnati8

Unknown

不适用

Treatment of Drooling With Type A Botulinum Toxin in Children With Cerebral PalsyDroolingCerebral Palsy

NCT00173745National Taiwan University Hospital20